| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
| 04/07/2005 | US20050074775 assessing GST-pi expression levels in fixed or fixed and paraffin embedded tissues using primers; pharmacogenetics; determining antitumor platinum-based chemotherapeutic regimen |
| 04/07/2005 | US20050074770 Cloned mammalian histamine H4 receptor that couples to G-protein; for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 04/07/2005 | US20050074758 Prokineticin polypeptides, related compositions and methods |
| 04/07/2005 | US20050074751 Binding viral protein during latency life cycle; binding of antibodies to excellular segments of protein; immobilization; removal of infecting cells; autoimmune disease, lupus, antiarthritic agents |
| 04/07/2005 | US20050074507 Polyherbal formulation for hepatic and splenic disorders |
| 04/07/2005 | US20050074470 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 04/07/2005 | US20050074441 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome |
| 04/07/2005 | US20050074436 Systems and methods for treating patients with processed lipoaspirate cells |
| 04/07/2005 | US20050074416 lactic bacteria strain dairy in origin, may administer in an edible composition, adheres to tooth surface and produces growth inhibition factor |
| 04/07/2005 | DE10341923A1 Verwendung von Tolperison Use of Tolperisone |
| 04/07/2005 | DE10341240A1 Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Substituted Thienoimidazole, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 04/07/2005 | CA2540701A1 Proteins expressed in nk cells |
| 04/07/2005 | CA2539444A1 Hexa- and octahydro-pyrido[1,2-a]pyrazine derivatives with nk1 antagonistic activity |
| 04/07/2005 | CA2538215A1 Staple oligonucleotides and medicaments comprising the same |
| 04/07/2005 | CA2533873A1 Method for attenuating virulence of microbial pathogens and for inhibiting microbial biofilm formation |
| 04/06/2005 | EP1520043A2 METHODS FOR THE IDENTIFICATION OF IKKa FUNCTION AND OTHER GEN ES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 04/06/2005 | EP1520021A2 Antisense modulation of lrh1 expression |
| 04/06/2005 | EP1519956A2 Epha2 monoclonal antibodies and methods of use thereof |
| 04/06/2005 | EP1519939A2 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 04/06/2005 | EP1519933A1 Quinuclidine amide derivatives |
| 04/06/2005 | EP1519922A1 Di-aryl-substituted ethane pyridone pde4 inhibitors |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519754A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 04/06/2005 | EP1519746A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 04/06/2005 | EP1519742A2 Osteoclast-associated receptor |
| 04/06/2005 | EP1519733A1 Compositions for cancer therapy comprising saponins or sapogenins |
| 04/06/2005 | EP1519730A1 Novel use of imidazotriazinones |
| 04/06/2005 | EP1519728A1 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidine in the treatment of functional bowel disorder |
| 04/06/2005 | EP1519720A2 Novel formate salt of o-desmethyl-venlafaxine |
| 04/06/2005 | EP1419389A4 Method and apparatus for rapid determination of ligand-protein binding using charcoal adsorption |
| 04/06/2005 | EP1353909B1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents |
| 04/06/2005 | EP1334086B1 Phenoxyphenyl alkane sulfonates |
| 04/06/2005 | EP1307455B1 Inhibitors of alpha-l beta-2 mediated cell adhesion |
| 04/06/2005 | EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604909A Cyclic peptides as g-protein-coupled receptor antagonists |
| 04/06/2005 | CN1604901A Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/06/2005 | CN1604900A 6-aminomorphinane derivatives, method for production and use thereof |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1604783A Drug for treating a fibrotic disease through rna interfence |
| 04/06/2005 | CN1604773A Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine |
| 04/06/2005 | CN1604772A Transdermal transport of compounds |
| 04/06/2005 | CN1603342A Caspase-8 interacting proteins |
| 04/06/2005 | CN1603314A Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/06/2005 | CN1602956A Deactivated BCG for treating disease |
| 04/06/2005 | CN1602954A Pharmaceutical composition with liver cell protecting function |
| 04/06/2005 | CN1602946A Buccal tablets for treating acute and chronic pharyngitis and stomatitis and its preparation process |
| 04/06/2005 | CN1602942A Medicine for treating hepatitis and its preparing process |
| 04/06/2005 | CN1602934A Chinese medicinal powder for treating toothache |
| 04/06/2005 | CN1602932A Medicine for treating oral disease |
| 04/06/2005 | CN1602931A Compound Chinese medicinal formulation for treating chronic atrophic gastritis and its preparing method |
| 04/06/2005 | CN1602930A Safflower containing twelve components forming medicinal wine capable of strengthening spleen and tonifying kidney and its preparation process |
| 04/06/2005 | CN1602917A 'Shengmai' formulation and its preparation process |
| 04/06/2005 | CN1602915A Stomach motility promoting medicine for treating stomach and intestine function failure and its preparation |
| 04/06/2005 | CN1602903A Live-soothing fat-reducing powder and its preparation |
| 04/06/2005 | CN1602901A Usage of Huoxiang Zhengqi formulation in the preparation of functional stomach dyskinesis treating medicine |
| 04/06/2005 | CN1602900A Pharmaceutical composition for treating diarrhea, dysentery and eruptive disease |
| 04/06/2005 | CN1602894A Health protecting product composition with liver protecting and blood fat regulating function and its preparation |
| 04/06/2005 | CN1602891A Glucosidase oral liquid |
| 04/06/2005 | CN1602880A Method for inhibitting bone resorption |
| 04/06/2005 | CN1602879A Method for inhibitting bone resorption |
| 04/06/2005 | CN1602878A Preparation process of polyene phosphatidylcholine injection |
| 04/06/2005 | CN1602861A Buccal tablet for treating oral anaerobe infection disease and its manufacturing method |
| 04/06/2005 | CN1602851A Dripping pills of benactyzine hydrochloride and its preparation |
| 04/06/2005 | CN1602841A Immuno-modulatory agents administration form for whole body or local immunity disorder |
| 04/06/2005 | CN1195843C Solid culture method of antrodia camphorate, its cultured solid substance, and its product and application |
| 04/06/2005 | CN1195841C Nutritive wine for male |
| 04/06/2005 | CN1195778C Cell adhension inhibitors |
| 04/06/2005 | CN1195775C Glucoprotein having inhibitory activity to pyroric spirillar colonization |
| 04/06/2005 | CN1195773C Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/06/2005 | CN1195755C Pyrrolo [2, 3-d] pyrimidine compounds |
| 04/06/2005 | CN1195745C Antiviral macrocyclic compounds |
| 04/06/2005 | CN1195736C Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 04/06/2005 | CN1195542C Preventives for hepatopathy |
| 04/06/2005 | CN1195541C Medicine composition for treating chronic hepatitis B |
| 04/06/2005 | CN1195536C Superfine gastrodia tuber and American ginseng superfine powder buccal lozenge |
| 04/06/2005 | CN1195533C Medicine for treating cholelithiasis |
| 04/06/2005 | CN1195531C Chinese medicinal herbs prescription for treating hepatitis B |
| 04/06/2005 | CN1195530C Lactic acid bacteria strains capable of preventing diarrhea |
| 04/06/2005 | CN1195528C Pilose antler composition and method for preparing the same |
| 04/06/2005 | CN1195522C Benzodiazepine derivatives |
| 04/06/2005 | CN1195500C Orally disintegrable tablet |
| 04/06/2005 | CN1195494C Oral liquid mucoadhesive compositions |
| 04/06/2005 | CN1195483C Stable hydrogenated lupulone antibacterial oral compositions |
| 04/05/2005 | US6875868 Pteridine compounds for the treatment of psoriasis |
| 04/05/2005 | US6875846 Heterologous polypeptide of the TNF family |
| 04/05/2005 | US6875789 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/05/2005 | US6875779 Cyclooxygenase inhibitor |
| 04/05/2005 | US6875777 Compounds |
| 04/05/2005 | US6875767 (5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors |
| 04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 04/05/2005 | US6875736 Methods for identifying RNA binding compounds |
| 04/05/2005 | US6875597 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 04/05/2005 | US6875576 Detection of modulators of receptor binding activity; obtain sample containing receptor, incubate with modulator, monitor adjustment of binding activity of receptor |
| 04/05/2005 | US6875570 Proteins and nucleic acids encoding same |
| 04/05/2005 | US6875422 Oral treatment/care agent |
| 04/05/2005 | US6875018 Use of ozone for the treatment of root canals |
| 04/05/2005 | CA2339621C 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 04/05/2005 | CA2092694C Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria |